Advertisement
Screener

ONKURE THERAPEUTICS, INC. (OKUR) Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3

2.4 / 5 stars · 17/35 Roast Me

ONKURE THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3

ONKURE THERAPEUTICS, INC. (OKUR) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 · last filed 2026-08-04

  • ONKURE THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2026-06-30 was $0.00.
  • ONKURE THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2026-03-31 was $0.00.
  • ONKURE THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2025-12-31 was $0.00.
  • ONKURE THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2025-09-30 was $0.00.
  • ONKURE THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2025 was $0.00.
  • ONKURE THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2024 was $0.00.
  • ONKURE THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2023 was $0.00.
  • ONKURE THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2022 was $0.00.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 12 month
2026-06-30$0.00
10-Q · filed 2026-08-04
$0.00
derived: sum of 2 quarters · filed 2026-08-04
$0.00
derived: sum of 3 quarters · filed 2026-08-04
$0.00
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$0.00
10-Q · filed 2026-05-05
$0.00
derived: sum of 2 quarters · filed 2026-05-05
$0.00
derived: sum of 3 quarters · filed 2026-05-05
$0.00
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$0.00
derived: sum of 2 quarters · filed 2026-03-12
$0.00
derived: sum of 3 quarters · filed 2026-08-04
$0.00
10-K · filed 2026-03-12
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2026-08-04
$0.00
10-Q · filed 2025-11-06
$0.00
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$0.00
10-Q · filed 2026-08-04
$0.00
10-Q · filed 2025-08-12
$0.00
derived: sum of 3 quarters · filed 2026-08-04
$0.00
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$0.00
10-Q · filed 2026-05-05
$0.00
derived: sum of 2 quarters · filed 2026-05-05
$0.00
derived: sum of 3 quarters · filed 2026-05-05
$0.00
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$0.00
derived: sum of 2 quarters · filed 2026-03-12
$0.00
derived: sum of 3 quarters · filed 2026-03-12
$0.00
10-K · filed 2026-03-12
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2025-11-06
$0.00
10-Q · filed 2025-11-06
$0.00
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$0.00
10-Q · filed 2025-08-12
$0.00
derived: sum of 3 quarters · filed 2025-08-12
$0.00
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$0.00
10-Q · filed 2025-05-06
$0.00
derived: sum of 2 quarters · filed 2025-05-06
$0.00
derived: sum of 3 quarters · filed 2025-05-06
$0.00
derived: sum of 4 quarters · filed 2025-05-06
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
$0.00
derived: sum of 2 quarters · filed 2025-03-10
$0.00
derived: sum of 3 quarters · filed 2025-03-10
$0.00
10-K · filed 2025-03-10
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$0.00
derived: sum of 2 quarters · filed 2023-11-13
$0.00
10-Q · filed 2023-11-13
$0.00
derived: sum of 4 quarters · filed 2024-03-28
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$0.00
10-Q · filed 2023-08-10
$0.00
derived: sum of 3 quarters · filed 2024-03-28
$0.00
derived: sum of 4 quarters · filed 2024-03-28
2023-03-31$0.00
10-Q · filed 2023-05-11
$0.00
derived: sum of 2 quarters · filed 2024-03-28
$0.00
derived: sum of 3 quarters · filed 2024-03-28
$0.00
derived: sum of 4 quarters · filed 2024-03-28
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$0.00
derived: sum of 2 quarters · filed 2024-03-28
$0.00
derived: sum of 3 quarters · filed 2024-03-28
$0.00
10-K · filed 2024-03-28
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$0.00
derived: sum of 2 quarters · filed 2022-11-08
$0.00
10-Q · filed 2022-11-08
$0.00
derived: sum of 4 quarters · filed 2023-03-27
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$0.00
10-Q · filed 2022-08-09
$0.00
derived: sum of 3 quarters · filed 2023-03-27
$0.00
derived: sum of 4 quarters · filed 2023-03-27
2022-03-31$0.00
10-Q · filed 2022-05-10
$0.00
derived: sum of 2 quarters · filed 2023-03-27
$0.00
derived: sum of 3 quarters · filed 2023-03-27
$0.00
derived: sum of 4 quarters · filed 2023-03-27
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
$0.00
derived: sum of 2 quarters · filed 2023-03-27
$0.00
derived: sum of 3 quarters · filed 2023-03-27
$0.00
10-K · filed 2023-03-27
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$0.00
derived: sum of 2 quarters · filed 2021-11-12
$0.00
10-Q · filed 2021-11-12
$0.00
derived: sum of 4 quarters · filed 2022-03-23
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$0.00
10-Q · filed 2021-08-11
$0.00
derived: sum of 3 quarters · filed 2022-03-23
$0.00
derived: sum of 4 quarters · filed 2022-03-23
2021-03-31$0.00
10-Q · filed 2021-05-20
$0.00
derived: sum of 2 quarters · filed 2022-03-23
$0.00
derived: sum of 3 quarters · filed 2022-03-23
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23
$0.00
derived: sum of 2 quarters · filed 2022-03-23
$0.00
10-K · filed 2022-03-23
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$0.00
10-Q · filed 2021-11-12
2020-06-30$0.00
10-Q · filed 2021-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27